LLIN Evaluation in Uganda Project (LLINEUP): a cross-sectional survey of species diversity and insecticide resistance in 48 districts of Uganda.


Journal

Parasites & vectors
ISSN: 1756-3305
Titre abrégé: Parasit Vectors
Pays: England
ID NLM: 101462774

Informations de publication

Date de publication:
12 Mar 2019
Historique:
received: 14 11 2018
accepted: 26 02 2019
entrez: 15 3 2019
pubmed: 15 3 2019
medline: 9 4 2019
Statut: epublish

Résumé

Long-lasting insecticidal nets (LLINs) are the principal tool for malaria control in Africa and are presently treated with a single class of insecticide; however, increasing levels of insecticide resistance threaten their success. In response to this threat nets have been developed that incorporate the synergist, piperonyl butoxide (PBO), which inhibits the activity of cytochrome P450s which is one main mechanisms of insecticide resistance, allowing resistance to pyrethroids to be reversed. However, data on the value and cost effectiveness of these nets is lacking. A large-scale cluster randomised trial of conventional LLINs and PBO-LLINs was conducted in Uganda in 104 health sub-districts (HSDs) in 2017-2019. Prior to the mass distribution of LLINs, a baseline entomological survey was carried out, the results of which are reported herein. Ten households from each HSD were randomly selected for entomological surveillance at baseline which included household mosquito collections. Prior to LLIN distribution entomological collections were carried out in 1029 houses across the 104 HSDs. Anopheles gambiae (s.l.) was the principal vector in all but 9 of the 71 HSDs that yielded vector species. Molecular analysis found An. gambiae (s.s.) to be the predominant vector collected. Plasmodium falciparum was detected in 5.5% of An. gambiae (s.s.) and in 4.0% of An. funestus (s.s.) examined. Infection rates of other plasmodium species (P. vivax, P. ovale and P. malariae) were lower with infection rates of 1.2% and 1.7% for An. gambiae (s.s.) and An. funestus (s.s.), respectively. The knockdown resistance (kdr) mutation Vgsc-L1014S was found at very high frequency in An. gambiae (s.s.) with the Vgsc-L1014F mutation at low frequency and the wild-type allele virtually absent. In An. arabiensis the wild-type allele was predominant. The resistance-associated alleles, Cyp4j5-L43F and Coeae1d were found at moderate frequencies which varied across the study site. Vgsc-N1575Y mutation was not found in any samples examined. No significant differences between planned intervention arms was observed in vector densities, sporozoite infection rate or insecticide resistance marker frequency across the study site prior to the distribution of LLINs. Very high levels of kdr resistance were observed in all areas; however, the resistance-associated markers Cyp4j5-L43F and Coeae1d were found at varying frequencies across the study site which may have implications for the effectiveness of standard LLINs. Trial registration This study is registered with ISRCTN, ISRCTN17516395. Registered 14 February 2017, http://www.isrctn.com/ISRCTN17516395.

Sections du résumé

BACKGROUND BACKGROUND
Long-lasting insecticidal nets (LLINs) are the principal tool for malaria control in Africa and are presently treated with a single class of insecticide; however, increasing levels of insecticide resistance threaten their success. In response to this threat nets have been developed that incorporate the synergist, piperonyl butoxide (PBO), which inhibits the activity of cytochrome P450s which is one main mechanisms of insecticide resistance, allowing resistance to pyrethroids to be reversed. However, data on the value and cost effectiveness of these nets is lacking. A large-scale cluster randomised trial of conventional LLINs and PBO-LLINs was conducted in Uganda in 104 health sub-districts (HSDs) in 2017-2019. Prior to the mass distribution of LLINs, a baseline entomological survey was carried out, the results of which are reported herein. Ten households from each HSD were randomly selected for entomological surveillance at baseline which included household mosquito collections.
RESULTS RESULTS
Prior to LLIN distribution entomological collections were carried out in 1029 houses across the 104 HSDs. Anopheles gambiae (s.l.) was the principal vector in all but 9 of the 71 HSDs that yielded vector species. Molecular analysis found An. gambiae (s.s.) to be the predominant vector collected. Plasmodium falciparum was detected in 5.5% of An. gambiae (s.s.) and in 4.0% of An. funestus (s.s.) examined. Infection rates of other plasmodium species (P. vivax, P. ovale and P. malariae) were lower with infection rates of 1.2% and 1.7% for An. gambiae (s.s.) and An. funestus (s.s.), respectively. The knockdown resistance (kdr) mutation Vgsc-L1014S was found at very high frequency in An. gambiae (s.s.) with the Vgsc-L1014F mutation at low frequency and the wild-type allele virtually absent. In An. arabiensis the wild-type allele was predominant. The resistance-associated alleles, Cyp4j5-L43F and Coeae1d were found at moderate frequencies which varied across the study site. Vgsc-N1575Y mutation was not found in any samples examined.
CONCLUSIONS CONCLUSIONS
No significant differences between planned intervention arms was observed in vector densities, sporozoite infection rate or insecticide resistance marker frequency across the study site prior to the distribution of LLINs. Very high levels of kdr resistance were observed in all areas; however, the resistance-associated markers Cyp4j5-L43F and Coeae1d were found at varying frequencies across the study site which may have implications for the effectiveness of standard LLINs. Trial registration This study is registered with ISRCTN, ISRCTN17516395. Registered 14 February 2017, http://www.isrctn.com/ISRCTN17516395.

Identifiants

pubmed: 30867018
doi: 10.1186/s13071-019-3353-7
pii: 10.1186/s13071-019-3353-7
pmc: PMC6417037
doi:

Substances chimiques

Insecticides 0
Pesticide Synergists 0
Pyrethrins 0
Piperonyl Butoxide LWK91TU9AH

Banques de données

ISRCTN
['ISRCTN17516395']

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

94

Subventions

Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : NIAID NIH HHS
ID : R01 AI116811
Pays : United States
Organisme : National Institute of Allergy and Infectious Diseases
ID : R01AI116811
Organisme : Wellcome Trust
ID : Oruni-203511/Z/16/Z
Pays : United Kingdom

Références

Am J Trop Med Hyg. 2002 Jun;66(6):804-11
pubmed: 12224596
Syst Biol. 2003 Oct;52(5):696-704
pubmed: 14530136
Nucleic Acids Res. 2004 Mar 19;32(5):1792-7
pubmed: 15034147
Am J Trop Med Hyg. 2007 Feb;76(2):334-9
pubmed: 17297045
Malar J. 2007 Aug 13;6:111
pubmed: 17697325
Malar J. 2008 May 26;7:92
pubmed: 18503715
Malar J. 2008 Aug 25;7:163
pubmed: 18724871
Malar J. 2008 Sep 15;7:177
pubmed: 18793416
PLoS Genet. 2008 Nov;4(11):e1000286
pubmed: 19043575
Nucleic Acids Res. 2010 Jan;38(Database issue):D492-6
pubmed: 19854944
J Med Entomol. 2009 Nov;46(6):1256-9
pubmed: 19960668
Am J Trop Med Hyg. 2010 Apr;82(4):566-73
pubmed: 20348500
Acta Trop. 2012 Mar;121(3):184-95
pubmed: 21420377
Proc Natl Acad Sci U S A. 2012 Apr 17;109(16):6147-52
pubmed: 22460795
Proc Natl Acad Sci U S A. 2012 Apr 24;109(17):6614-9
pubmed: 22493253
PLoS One. 2012;7(4):e34841
pubmed: 22514674
PLoS One. 2012;7(8):e42857
pubmed: 22880123
Med Vet Entomol. 2013 Sep;27(3):276-83
pubmed: 23046446
Am J Trop Med Hyg. 2013 May;88(5):855-61
pubmed: 23458956
PLoS Genet. 2014 Mar 20;10(3):e1004236
pubmed: 24651294
Malar J. 2014 Mar 21;13:111
pubmed: 24656206
Mol Genet Genomics. 2015 Feb;290(1):201-15
pubmed: 25213601
Nature. 2015 Oct 8;526(7572):207-211
pubmed: 26375008
Insect Biochem Mol Biol. 2016 Jan;68:23-32
pubmed: 26548743
Parasit Vectors. 2015 Dec 01;8:616
pubmed: 26626424
Trends Parasitol. 2016 Mar;32(3):197-206
pubmed: 26750864
Lancet. 2016 Apr 23;387(10029):1785-8
pubmed: 26880124
PLoS Med. 2016 Nov 8;13(11):e1002167
pubmed: 27824885
Malar J. 2017 Apr 20;16(1):156
pubmed: 28427415
Elife. 2017 Jun 23;6:
pubmed: 28643631
Wellcome Open Res. 2017 Jul 26;2:57
pubmed: 28884158
Wellcome Open Res. 2017 Aug 24;2:71
pubmed: 29018842
Sci Rep. 2018 Feb 13;8(1):2920
pubmed: 29440767
Malar J. 2018 Apr 6;17(1):157
pubmed: 29625585
Evol Appl. 2017 Dec 04;11(4):431-441
pubmed: 29636797
Lancet Infect Dis. 2018 Jun;18(6):640-649
pubmed: 29650424
Malar J. 2018 Nov 6;17(1):412
pubmed: 30400885
Malar J. 2018 Nov 13;17(1):421
pubmed: 30424775
Trans R Soc Trop Med Hyg. 1979;73(5):483-97
pubmed: 394408
Nature. 1977 Apr 28;266(5605):832-3
pubmed: 865604

Auteurs

Amy Lynd (A)

Liverpool School of Tropical Medicine, Pembroke Place, Liverpool, L3 5QA, UK. amy.lynd@lstmed.ac.uk.

Samuel Gonahasa (S)

Infectious Diseases Research Collaboration, 2C Nakasero Hill Road, Kampala, Uganda.

Sarah G Staedke (SG)

London School of Hygiene & Tropical Medicine, Keppel Street, London, WC1E 7HT, UK.

Ambrose Oruni (A)

Liverpool School of Tropical Medicine, Pembroke Place, Liverpool, L3 5QA, UK.

Catherine Maiteki-Sebuguzi (C)

Infectious Diseases Research Collaboration, 2C Nakasero Hill Road, Kampala, Uganda.
National Malaria Control Programme, Uganda Ministry of Health, Kampala, Uganda.

Grant Dorsey (G)

University of California, San Francisco, San Francisco, CA, 94110, USA.

Jimmy Opigo (J)

National Malaria Control Programme, Uganda Ministry of Health, Kampala, Uganda.

Adoke Yeka (A)

Infectious Diseases Research Collaboration, 2C Nakasero Hill Road, Kampala, Uganda.

Agaba Katureebe (A)

Infectious Diseases Research Collaboration, 2C Nakasero Hill Road, Kampala, Uganda.

Mary Kyohere (M)

Infectious Diseases Research Collaboration, 2C Nakasero Hill Road, Kampala, Uganda.

Janet Hemingway (J)

Liverpool School of Tropical Medicine, Pembroke Place, Liverpool, L3 5QA, UK.

Moses R Kamya (MR)

Infectious Diseases Research Collaboration, 2C Nakasero Hill Road, Kampala, Uganda.

Martin J Donnelly (MJ)

Liverpool School of Tropical Medicine, Pembroke Place, Liverpool, L3 5QA, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH